Arthur H. Rubenstein, MBBCh Professor
Scientific Director, Abramson Family Cancer Research Institute
Associate Director of Shared Resources, Abramson Cancer Center, Department of Cell and Developmental Biology
University of Pennsylvania, Perelman School of Medicine
For lauded research contributions that have informed the understanding of cancer metabolism, oxygen biology, and tumor hypoxia resulting in the development of murine cancer models and the elucidation of the role of hypoxia-inducible factor-2 alpha in tumorigenesis, which has since led to the development of the FDA approved therapeutic belzutifan for the treatment of von Hippel–Lindau disease associated renal cell carcinoma.
The AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research was established by the AACR and Eli Lilly and Co. in 1961 to honor Dr. G.H.A. Clowes, who was a founding member of the AACR and a research director at Eli Lilly. The award is intended to recognize an individual who has made outstanding recent accomplishments in basic cancer research. To learn more, please visit the press release.
View Dr. Simon’s Fellows of the AACR Academy page.
View Past Recipients